- Home
- KURA vs MMI Comparison
KURA vs MMI Comparison
Compare KURA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- MMI
- Stock Information
- Founded
- KURA 2014
- MMI 1971
- Country
- KURA United States
- MMI United States
- Employees
- KURA N/A
- MMI N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- MMI Real Estate
- Sector
- KURA Health Care
- MMI Finance
- Exchange
- KURA Nasdaq
- MMI Nasdaq
- Market Cap
- KURA 1.0B
- MMI 1.2B
- IPO Year
- KURA N/A
- MMI 2013
- Fundamental
- Price
- KURA $12.08
- MMI $30.15
- Analyst Decision
- KURA Buy
- MMI Sell
- Analyst Count
- KURA 11
- MMI 2
- Target Price
- KURA $25.00
- MMI $29.00
- AVG Volume (30 Days)
- KURA 2.2M
- MMI 194.2K
- Earning Date
- KURA 11-04-2025
- MMI 11-07-2025
- Dividend Yield
- KURA N/A
- MMI 1.69%
- EPS Growth
- KURA N/A
- MMI N/A
- EPS
- KURA N/A
- MMI N/A
- Revenue
- KURA $104,029,000.00
- MMI $751,284,000.00
- Revenue This Year
- KURA $68.63
- MMI $10.89
- Revenue Next Year
- KURA $141.59
- MMI $16.32
- P/E Ratio
- KURA N/A
- MMI N/A
- Revenue Growth
- KURA N/A
- MMI 20.74
- 52 Week Low
- KURA $5.41
- MMI $27.35
- 52 Week High
- KURA $12.49
- MMI $42.53
- Technical
- Relative Strength Index (RSI)
- KURA 66.94
- MMI 53.65
- Support Level
- KURA $10.86
- MMI $29.01
- Resistance Level
- KURA $11.88
- MMI $30.30
- Average True Range (ATR)
- KURA 0.88
- MMI 0.97
- MACD
- KURA 0.08
- MMI 0.07
- Stochastic Oscillator
- KURA 85.86
- MMI 56.25
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.